Stocks · Health care · Pharmaceutical Preparations

PepGen Inc.

PEPG Clue Score35
United States Fiscal year ends December CIK 0001835597 Results filed 6 Aug 2026

What the insiders did Net selling

By person

8 insiders · 7 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
James G McArthur
President and CEO
—
$32.88K (2)
−$32.88K
296,326
$418.03K
+17,393%
Noel Donnelly
Chief Financial Officer
—
$12.99K (2)
−$12.99K
111,603
$157.44K
+834.9%
Paul Streck
EVP, Head of R&D
—
$11.71K (2)
−$11.71K
76,226
$107.53K
—
Kasra Kasraian
Chief Technical Officer
—
$1.74K (1)
−$1.74K
50,074
$70.64K
—
Ra Capital Management, L.p. entity
Director
—
—
—
18,554,273
$26.17M
+102.1%
Oxford Science Enterprises plc entity
Former 10% Owner
—
—
—
4,955,388
$6.99M
+4.2%
Joseph Vittiglio
Chief Business & Legal Officer
—
—
—
65,717
$92.71K
—
Mary Beth DeLena
General Counsel
—
—
—
14,968
$21.12K
—

No percentages here. This company's share count has moved by a factor of 2.1 over the window, from 32,720,943 to 69,259,517 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.